Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.
Mandeep R. Mehra, MD, FACC, FACP, FRCP
Advertisement
Articles by Mandeep R. Mehra, MD, FACC, FACP, FRCP
Advertisement
Latest Updated Articles
- Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients
Published: January 20th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
